
Curious About HRT? What to Expect at Your First Visit
If you’re considering hormone replacement therapy for perimenopause or menopause, here’s how to prepare for a productive first visit.
Curious About HRT? What to Expect at Your First Visit
Revised on Oct. 10, 2026
Most people are familiar with estrogen when it comes to women’s hormones, but testosterone plays just as big a role—and sometimes an even bigger one.
Did You Know? Women have about 20 times more testosterone than estrogen between ages 20 and 50.
Your ovaries are the primary producers of testosterone, which is then converted into estrogen. So when testosterone is low, estrogen usually is too. That’s why focusing only on estrogen replacement actually misses the bigger picture—testosterone is the “master sex hormone” for women.
As women age, their ovaries gradually produce fewer hormones. This drop doesn’t happen overnight—it can take years, and hormone levels can swing wildly during this time. Common symptoms include:
Hot flashes and night sweats (vasomotor symptoms)
Brain fog and decreased sharpness
Lower energy, libido, and mood
Dry eyes, skin, and vagina
Technically, menopause is defined as going a full year without a period or having your ovaries removed. But most women start experiencing symptoms years before that—this is called perimenopause. The average age for menopause in the U.S. is about 54, but it can happen years earlier or later.
Labs can measure hormone levels, but they don’t tell the whole story. Hormones like estrogen and testosterone fluctuate constantly, so a single blood test might give a false sense of security—or doom.
Dr. Mok’s Perspective: “We love our tests, but they’re just not that accurate for hormones. Menopause is really a clinical diagnosis, based on symptoms and age—not lab numbers.”
There are other tests, like saliva and urine samples, but these are hard to interpret and not very helpful. Bloodwork can confirm you’re approaching menopause, but if you’re a certain age and haven’t had a period in a year, you know you’re in menopause. The labs rarely change the treatment plan.
The History (and Drama) of Hormone Replacement Therapy A century ago, menopause was dismissed as “hysteria” or a mental health issue. The first hormone therapies were made from ground-up sheep ovaries. Strange as that sounds, we still use animal-derived hormones for certain conditions today.
Eventually, the pharmaceutical industry developed Premarin, made from the urine of pregnant horses. This was a breakthrough for treating menopause symptoms, but it also came with risks: using Premarin alone could cause the uterine lining to overgrow, sometimes leading to cancer. Doctors added progesterone to balance this, and for a time, combination therapy became the standard.
By the 1990s, Premarin plus progesterone was the most-prescribed drug for women in the world. Large studies even showed that women on these hormones lived longer than those who took nothing.
Then came the Women’s Health Initiative Trial in the early 2000s—a turning point that many experts now consider a huge setback for women’s health. The study suggested a tiny increase in breast cancer risk (just 0.08%), but no increase in deaths. It also hinted at more heart disease, but later analysis showed the opposite: women on estrogen had fewer heart attacks and less breast cancer, especially if they started treatment within ten years of menopause.
What Actually Happened? The study’s results were widely misunderstood, and hormone therapy prescriptions plummeted. Instead, women were given new medications—diabetes drugs, bone medications, antidepressants—to treat symptoms hormones once relieved.
As the risks of synthetic hormones became a concern, some doctors started using “bioidentical” or natural hormones. These are chemically identical to the hormones your body naturally makes. For example:
Estradiol (the main female hormone)
Progesterone (not synthetic progestins)
Testosterone (already used in other countries for women)
Research from other countries showed that women using both testosterone and estrogen had 30-70% less breast cancer than those in the major U.S. studies.
FDA Facts: There’s no FDA-approved commercial testosterone product for women in the U.S.—but testosterone is FDA-approved for women (for metastatic breast cancer) and has been for decades.
Allure Medicals’s approach is to replace hormones as if the ovaries were still working like they did at age 30, using:
Testosterone pellets
(custom-compounded, inserted under the skin)
A small amount of estrogen
Oral progesterone
(taken at night, since it can help with sleep)
Typical dosing is weight-based: about 1 mg per pound of testosterone, with much less estrogen (around 1/20th that dose). Progesterone is usually 100-200 mg at bedtime.
Important: There are many ways to do hormone replacement, and what matters most is that you feel well. Allure Medical prefers bioidentical hormones and avoids synthetic progestins and estrogens. If you’re doing something that works for you, stick with it.
Not all forms are equally effective. Topical testosterone rarely delivers reliable levels, and injectable testosterone isn’t ideal for women. Patches and other methods can work, but may not be as physiologic.
Menopause and perimenopause are clinical diagnoses; lab tests don’t tell the whole story.
Symptoms matter most —treatment should be based on how you feel, not just your numbers.
Bioidentical hormone therapy (testosterone, estradiol, progesterone) is a modern, evidence-based approach.
History matters: Much of the fear around hormone therapy comes from misinterpreted research.
Talk with your doctor about what’s right for you—and don’t dismiss your symptoms.
If you’re struggling with menopausal symptoms, know that you have options. The science is evolving, and so are the treatments.
Yes. Testosterone is part of normal female hormone physiology and contributes to sexual function. However, having a lower testosterone level does not automatically mean treatment is needed. Symptoms, medical history, and other possible causes should be evaluated together.
Reduced sexual desire may prompt a discussion about testosterone, particularly when it causes distress. Fatigue, low mood, and difficulty concentrating are less specific and do not establish a testosterone deficiency. These concerns deserve an assessment rather than an assumption that testosterone treatment will resolve them.
A testosterone result alone cannot diagnose the cause of low sexual desire. There is no established blood-level cutoff that separates women with and without sexual dysfunction. Testing can still be useful before and during treatment to identify elevated levels and help prevent excessive dosing.
The strongest evidence supports testosterone therapy for selected postmenopausal women with hypoactive sexual desire disorder (HSDD)—persistent low sexual desire that causes personal distress. Treatment should follow an assessment of medical, medication-related, psychological, and relationship factors that may contribute.
Testosterone is not an established treatment for hot flashes, fatigue, brain fog, or general well-being. Other menopause treatments may be more appropriate, depending on the symptoms and diagnosis. Increasing testosterone to address these concerns can expose patients to risks without a proven benefit.
There is no FDA-approved testosterone formulation for managing menopausal symptoms in women in the United States. Clinicians sometimes prescribe testosterone off-label for appropriately evaluated patients. Off-label prescribing requires a discussion of expected benefits, potential side effects, and uncertainties about long-term safety.
Pellets have not been established as the preferred treatment for women. They cannot be easily adjusted or discontinued after insertion. ACOG recommends preparations other than pellets for testosterone delivery because of limited safety evidence and difficulty removing them. Carefully dosed transdermal treatment may be considered for appropriate patients.
“Bioidentical” describes hormones with the same molecular structure as hormones produced by the body. It does not guarantee greater safety. FDA-approved bioidentical estrogen and progesterone products are available; compounded products have not demonstrated superior safety or effectiveness.
Possible side effects include acne and increased facial or body hair. Excessive testosterone exposure may also cause scalp hair thinning or voice changes, some of which can persist. Long-term cardiovascular and breast safety remain uncertain, making appropriate dosing and follow-up important.
Testosterone should not be prescribed to prevent breast cancer. Current evidence does not establish a protective benefit, and long-term breast safety has not been adequately determined. Patients with a breast cancer history should discuss hormone treatment with their oncology and menopause care teams.
An Allure Medical consultation can help you discuss symptoms, review your medical history, and understand available treatment options. Ask about the evidence for your proposed treatment, its FDA approval status, alternatives, monitoring, and how side effects would be managed.